You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 30.7 KDa. Observed: 30 KDa, reducing conditions
Human
Met1-Leu259
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.2 KDa. Observed: 20 KDa, reducing conditions
Human
Met1-Lys117
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 33.4 KDa. Observed: 36 KDa, reducing conditions
Human
Met1-Pro277
N-6His
10 μg, 50 μg, 1 mg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 117 KDa. Observed: 115 KDa, reducing conditions
Human
Pro2-Gln1066
Tag free
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 16.23 KDa. Observed: 19 KDa, reducing conditions
Human
Met1-Tyr133
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.14 KDa. Observed: 19 KDa, reducing conditions
Human
Gly132-Ser301
N-GST
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.9 KDa. Observed: 17 KDa, reducing conditions
Human
Met1-Pro156
C-6His
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.8 KDa. Observed: 18 KDa, reducing conditions
Human
Met1-Ser154
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.3 KDa. Observed: 16 KDa, reducing conditions
Human
Met1-Ser109
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.3 KDa. Observed: 17 KDa, reducing conditions
Human
Met1-Gln168
N-6His
10 μg, 50 μg, 500 μg, 1 mg